DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Alzheimer Disease D000544 76 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Colorectal Neoplasms D015179 10 associated lipids
Optic Nerve Diseases D009901 6 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Psoriasis D011565 47 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Brain Infarction D020520 17 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Qu L et al. Enhancement of docosahexaenoic acid production by Schizochytrium sp. using a two-stage oxygen supply control strategy based on oxygen transfer coefficient. 2011 Lett. Appl. Microbiol. pmid:21070268
Kim HW et al. Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain. 2011 Biochim. Biophys. Acta pmid:21070866
Sidhu VK et al. Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)O/(18)O labeling. 2011 J. Proteome Res. pmid:22003853
Granot E et al. DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response. 2011 Mediators Inflamm. pmid:21941411
Westphal C et al. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? 2011 Prostaglandins Other Lipid Mediat. pmid:21945326
Decsi T et al. Inverse association between trans isomeric and long-chain polyunsaturated fatty acids in pregnant women and their newborns: data from three European countries. 2011 Ann. Nutr. Metab. pmid:22142767
Hashimoto M et al. Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells. 2011 J. Nutr. Biochem. pmid:20226652
Kohlboeck G et al. Effect of fatty acid status in cord blood serum on children's behavioral difficulties at 10 y of age: results from the LISAplus Study. 2011 Am. J. Clin. Nutr. pmid:22071708
Park CK et al. Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. 2011 J. Neurosci. pmid:22016541
James S et al. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). 2011 Cochrane Database Syst Rev pmid:22071839
Chang WK et al. The comparison of protein-entrapped liposomes and lipoparticles: preparation, characterization, and efficacy of cellular uptake. 2011 Int J Nanomedicine pmid:22072876
Hull MA Omega-3 polyunsaturated fatty acids. 2011 Best Pract Res Clin Gastroenterol pmid:22122770
Turgut S et al. The effects of docosahexaenoic acid supplementation and exercise on growth hormone and insulin-like growth factor I serum levels during chronic hypoxia in rats. 2011 J Basic Clin Physiol Pharmacol pmid:22865430
Morin C et al. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21057106
Kumosani TA and Moselhy SS Modulatory effect of cod-liver oil on Na(+)-K(+) ATPase in rats' brain. 2011 Hum Exp Toxicol pmid:20488854
Zeng Y et al. Development of a temperature shift strategy for efficient docosahexaenoic acid production by a marine fungoid protist, Schizochytrium sp. HX-308. 2011 Appl. Biochem. Biotechnol. pmid:21120635
Itakura H et al. Relationships between plasma fatty acid composition and coronary artery disease. 2011 J. Atheroscler. Thromb. pmid:21099130
Sullivan JC et al. Modeling the primary oxidation in commercial fish oil preparations. 2011 Lipids pmid:21104333
Johnsen GM et al. Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. 2011 Placenta pmid:21741084
Keithly JI et al. Thermogenesis, blood metabolites and hormones, and growth of lambs born to ewes supplemented with algae-derived docosahexaenoic acid. 2011 J. Anim. Sci. pmid:21742943
Sun H et al. Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. 2011 Carcinogenesis pmid:21771724
Opreanu M et al. The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models. 2011 Diabetes pmid:21771974
Kalupahana NS et al. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. 2011 Adv Nutr pmid:22332072
Wiese DM et al. The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients. 2011 Nutr Clin Pract pmid:21775642
Madec S et al. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload. 2011 Drug Metab. Dispos. pmid:21778351
Klingler M et al. Fatty acid status determination by cheek cell sampling combined with methanol-based ultrasound extraction of glycerophospholipids. 2011 Lipids pmid:21681560
Friedrichs W et al. Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression. 2011 Nutr Cancer pmid:21667400
Sakayori N et al. Distinctive effects of arachidonic acid and docosahexaenoic acid on neural stem /progenitor cells. 2011 Genes Cells pmid:21668588
Shulse CN and Allen EE Widespread occurrence of secondary lipid biosynthesis potential in microbial lineages. 2011 PLoS ONE pmid:21629834
Okpala I et al. Pilot study of omega-3 fatty acid supplements in sickle cell disease. 2011 APMIS pmid:21635551
Hajjaji N et al. Determinants of DHA incorporation into tumor tissue during dietary DHA supplementation. 2011 Lipids pmid:21638063
Schuchardt JP et al. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil. 2011 Lipids Health Dis pmid:21854650
Beck G et al. Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. 2011 J. Neurosci. pmid:21813701
Konrad M et al. The acute effect of ingesting a quercetin-based supplement on exercise-induced inflammation and immune changes in runners. 2011 Int J Sport Nutr Exerc Metab pmid:21813917
Morin C et al. 19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca²⁺ sensitivity in human pulmonary arteries. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21821782
McLaren JE et al. Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages. 2011 Lipids pmid:21822944
Kawabata T et al. Associations between dietary n-6 and n-3 fatty acids and arachidonic acid compositions in plasma and erythrocytes in young and elderly Japanese volunteers. 2011 Lipids Health Dis pmid:21838914
Tian H et al. Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions. 2011 Am. J. Pathol. pmid:21839062
Kimura F et al. Supplementation of DHA-rich microalgal oil or fish oil during the suckling period in mildly n-3 fatty acid-deficient rat pups. 2011 Lipids pmid:21901511
Trojian TH and Jackson E Ω-3 polyunsaturated fatty acids and concussions: treatment or not? 2011 Curr Sports Med Rep pmid:23531891
Collins CT et al. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. 2011 Br. J. Nutr. pmid:21443815
Sala-Vila A et al. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. 2011 Br. J. Nutr. pmid:21450116
Vincentini O et al. Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA2. 2011 Clin Nutr pmid:21421277
Weylandt KH et al. Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α. 2011 Carcinogenesis pmid:21421544
Stapleton RD et al. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. 2011 Crit. Care Med. pmid:21423000
Kulkarni A et al. Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats. 2011 PLoS ONE pmid:21423696
Hong WK et al. Production of lipids containing high levels of docosahexaenoic acid by a newly isolated microalga, Aurantiochytrium sp. KRS101. 2011 Appl. Biochem. Biotechnol. pmid:21424706
Nelson TL et al. Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females. 2011 Eur J Nutr pmid:20706728
Bhatia HS et al. Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. 2011 PLoS ONE pmid:22163304
Wagner K et al. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. 2011 Prostaglandins Other Lipid Mediat. pmid:21854866
Park CK et al. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. 2011 J. Neurosci. pmid:22171045
Zúñiga J et al. N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. 2011 PLoS ONE pmid:22174823
Legrand P et al. Update of French nutritional recommendations for fatty acids. 2011 World Rev Nutr Diet pmid:21865827
Mancini I et al. Fatty acid composition of common barbel (Barbus barbus) roe and evaluation of its haemolytic and cytotoxic activities. 2011 Toxicon pmid:21510968
Hadders-Algra M Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations. 2011 Am. J. Clin. Nutr. pmid:21525202
Guesnet P et al. α-Linolenate reduces the dietary requirement for linoleate in the growing rat. 2011 Prostaglandins Leukot. Essent. Fatty Acids pmid:21880475
Escolano-Margarit MV et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. 2011 J. Nutr. pmid:21525247
Rockett BD et al. Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells. 2011 J. Nutr. pmid:21525263
De Franceschi G et al. Structural and morphological characterization of aggregated species of α-synuclein induced by docosahexaenoic acid. 2011 J. Biol. Chem. pmid:21527634
Schnebelen C et al. Dietary polyunsaturated fatty acids reduce retinal stress induced by an elevation of intraocular pressure in rats. 2011 Nutr Res pmid:21530802
Glew RH et al. Low docosahexaenoic acid in the diet and milk of American Indian women in New Mexico. 2011 J Am Diet Assoc pmid:21515123
Michaelsen KF et al. Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6-24 months), and pregnant and lactating women. 2011 Matern Child Nutr pmid:21366872
Sun C et al. DHA regulates lipogenesis and lipolysis genes in mice adipose and liver. 2011 Mol. Biol. Rep. pmid:20383747
Kim SH et al. Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability. 2011 Eur J Clin Nutr pmid:20877395
Hutchins HL et al. Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. 2011 J. Nutr. Biochem. pmid:20951563
Gibson RA et al. Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life. 2011 Matern Child Nutr pmid:21366864
Lauritzen L and Carlson SE Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. 2011 Matern Child Nutr pmid:21366866
Brenna JT Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early post-natal life. 2011 Matern Child Nutr pmid:21366867
Blasbalg TL et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. 2011 Am. J. Clin. Nutr. pmid:21367944
Neubronner J et al. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. 2011 Eur J Clin Nutr pmid:21063431
Klein CM and Jenkins TC Docosahexaenoic acid elevates trans-18:1 isomers but is not directly converted into trans-18:1 isomers in ruminal batch cultures. 2011 J. Dairy Sci. pmid:21854940
Miyazawa D et al. Biochemical responses to dietary α-linolenic acid restriction proceed differently among brain regions in mice. 2011 Biomed. Res. pmid:21878731
Mazaki-Tovi M et al. Effect of omega-3 fatty acids on serum concentrations of adipokines in healthy cats. 2011 Am. J. Vet. Res. pmid:21879986
Kim HW et al. Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation. 2011 Prostaglandins Leukot. Essent. Fatty Acids pmid:21880477
Blum JL et al. Profiling of fatty acids released during calcium-induced mitochondrial permeability transition in isolated rabbit kidney cortex mitochondria. 2011 Toxicol In Vitro pmid:21443943
Salem N and Kuratko CN Lack of evidence for increased α-linolenic acid metabolism in vegetarians. 2011 Am. J. Clin. Nutr. pmid:21430120
Poudel-Tandukar K et al. Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women--the Japan Public Health Center-based (JPHC) prospective study. 2011 J Affect Disord pmid:20692041
Parra-Cabrera S et al. Dietary intakes of polyunsaturated fatty acids among pregnant Mexican women. 2011 Matern Child Nutr pmid:21410881
Safarinejad MR Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study. 2011 Andrologia pmid:21219381
Cotogni P et al. Impact of the omega-3 to omega-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells. 2011 JPEN J Parenter Enteral Nutr pmid:21224438
Burrows T et al. Omega-3 index, obesity and insulin resistance in children. 2011 Int J Pediatr Obes pmid:21226540
Min Y et al. Relationship between red cell membrane fatty acids and adipokines in individuals with varying insulin sensitivity. 2011 Eur J Clin Nutr pmid:21386858
Zhao Y et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models. 2011 PLoS ONE pmid:21246057
Gomez-Pinilla F The combined effects of exercise and foods in preventing neurological and cognitive disorders. 2011 Prev Med pmid:21281667
Feucht C and Patel DR Herbal medicines in pediatric neuropsychiatry. 2011 Pediatr. Clin. North Am. pmid:21281847
Galicia-Connolly EZ et al. Complementary, holistic, and integrative medicine: therapies for learning disabilities. 2011 Pediatr Rev pmid:21285298
Nobili V et al. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. 2011 Arch. Dis. Child. pmid:21233083
Yi SH et al. A cross-sectional study of docosahexaenoic acid status and cognitive outcomes in females of reproductive age with phenylketonuria. 2011 J. Inherit. Metab. Dis. pmid:21305356
Van Dyke TE Proresolving lipid mediators: potential for prevention and treatment of periodontitis. 2011 J. Clin. Periodontol. pmid:21323709
Harper KN et al. Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring. 2011 Schizophr. Res. pmid:21324652
Grimm MO et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. 2011 J. Biol. Chem. pmid:21324907
Umhau JC Docosahexaenoic acid supplementation and Alzheimer disease. 2011 JAMA pmid:21325181
Nowak M et al. Impact of polyunsaturated fatty acids on oxidized low density lipoprotein-induced U937 cell apoptosis. 2011 J. Atheroscler. Thromb. pmid:21325776
Murphy RA et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. 2011 Cancer pmid:21328326
Valera B et al. Influence of n-3 fatty acids on cardiac autonomic activity among Nunavik Inuit adults. 2011 Int J Circumpolar Health pmid:21329579
Hamazaki K et al. Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients. 2011 Am. J. Nephrol. pmid:21196723
Pawlik D et al. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. 2011 Pediatrics pmid:21199856
Lecchi C et al. In vitro modulation of caprine monocyte immune functions by ω-3 polyunsaturated fatty acids. 2011 Vet. J. pmid:20889357
Toufektsian MC et al. Dietary flavonoids increase plasma very long-chain (n-3) fatty acids in rats. 2011 J. Nutr. pmid:21068183
Liu C and Cai WX [Correlation between the eicosapentaenoic acid, docosahexaenoic acid and the aggressive behavior in mice]. 2011 Fa Yi Xue Za Zhi pmid:21604451